Ruocco, Antonio <br/><br/>
Farnesyl transferase inhibitors induce neuroprotection by inhibiting Ha-Ras signalling pathway.  [electronic resource] 

 -  The European journal of neuroscience  Dec 2007 
 - 3261-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0953-816X 
<br/><br/><label>Standard No.: </label>10.1111/j.1460-9568.2007.05935.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain--drug effects<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Disease Models, Animal<br/>Embryo, Mammalian<br/>Excitatory Amino Acid Agonists--toxicity<br/>Farnesyltranstransferase--metabolism<br/>Male<br/>Maleates--pharmacology<br/>Mice<br/>N-Methylaspartate--toxicity<br/>Neurons--drug effects<br/>Neuroprotective Agents--pharmacology<br/>Neurotoxicity Syndromes--etiology<br/>Proto-Oncogene Proteins p21(ras)--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Reactive Oxygen Species--metabolism<br/>Signal Transduction--drug effects<br/>Tetrazolium Salts<br/>Thiazoles